| ²é¿´: 685 | »Ø¸´: 2 | |||
sunxing1234гæ (³õÈëÎÄ̳)
|
[ÇóÖú]
Õæ³ÏÇóÖú¹ØÓÚBPÒ©µä¸½¼þµÄÎÊÌ⣡£¡£¡--ÔÚÏßµÈ ÒÑÓÐ1È˲ÎÓë
|
|
BPÖо³£»áÓÐÕâÑùÒ»¶Î»°£ºOther detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other/unspecified impurities and/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use): K. ÎÊÌâÊÇ¡°See also 5.10¡±ÊǵÄʲôÄÚÈÝ£¿ ¹òлÐֵܽãÃã¡£¡ |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£©
ÒѾÓÐ17È˻ظ´
302·ÖÇóµ÷¼Á Ò»Ö¾Ô¸°²»Õ´óѧ085601
ÒѾÓÐ12È˻ظ´
288»·¾³×¨Ë¶,Çóµ÷²ÄÁÏ·½Ïò
ÒѾÓÐ23È˻ظ´
»·¾³×¨Ë¶µ÷¼Á
ÒѾÓÐ6È˻ظ´
22408 µ÷¼Á²ÄÁÏ
ÒѾÓÐ6È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ19È˻ظ´
klicking
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- ACI: 9
- Ó¦Öú: 923 (²©ºó)
- ¹ó±ö: 0.652
- ½ð±Ò: 19319.5
- É¢½ð: 30
- ºì»¨: 149
- ɳ·¢: 1
- Ìû×Ó: 2337
- ÔÚÏß: 513.3Сʱ
- ³æºÅ: 1426293
- ×¢²á: 2011-10-03
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xl_pro: ½ð±Ò+2, ¸ÐлÄãµÄÓ¦Öú£¬ÐÁ¿àÁË£¡ 2015-11-08 11:08:23
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xl_pro: ½ð±Ò+2, ¸ÐлÄãµÄÓ¦Öú£¬ÐÁ¿àÁË£¡ 2015-11-08 11:08:23
| ÕâÓ¦¸ÃÊÇָŷÖÞÒ©µäͨÔò5.10 Control of impurities in substances for pharmaceutical use |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : 5.10.pdf
2015-11-07 07:47:30, 252.35 K

2Â¥2015-11-07 07:47:34
sunxing1234
гæ (³õÈëÎÄ̳)
![]() |
3Â¥2015-11-07 10:12:39














»Ø¸´´ËÂ¥
